Logo
x

Search

Subscribe Now

abl bio

ABL Bio Licenses Grabody-B Brain Delivery Platform to GSK for ~$2.76B (£2.15B)

ABL Bio Licenses Grabody-B Brain Delivery Platform to GSK for ~$2.76B (£2.15B)

  • April 7, 2025
ABL Bio Collaborates with Merck to Develop ABL103 Plus Keytruda for Treating Solid Tumors

ABL Bio Collaborates with Merck to Develop ABL103 Plus Keytruda for Treating Solid Tumors

  • October 4, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.